Is TB-500 the same as thymosin beta-4?

No. Thymosin beta-4 is the full 43-residue protein; TB-500 is a synthetic fragment corresponding to its actin-binding region. They differ in molecular weight and handling, and published literature on one does not automatically apply to the other.

What does actin sequestration mean?

The peptide binds monomeric G-actin and holds a reservoir of unpolymerised actin available for rapid filament assembly, which places it upstream of cell migration processes such as endothelial and keratinocyte movement.

Why are TB-500 and BPC-157 studied together?

They are investigated for complementary mechanisms in tissue-repair models — angiogenic signalling in the case of BPC-157 and cytoskeletal mobilisation in the case of TB-500.

Compound overviews · 6 min read

TB-500 and thymosin beta-4: the naming problem and the biology

Why TB-500 and thymosin beta-4 are not interchangeable names, what actin sequestration means mechanistically, and how the two materials differ in the laboratory.

The two are related but not identical

Thymosin beta-4 is a 43-residue naturally occurring protein, the principal actin-sequestering molecule in mammalian cells. TB-500 is a synthetic fragment corresponding to the actin-binding region — commonly the seven-residue LKKTETQ motif, frequently supplied as a longer partial sequence.

The names are used interchangeably in commercial listings, and they should not be. Full-length thymosin beta-4 and the synthetic fragment differ in molecular weight, in solubility behaviour, and in which published literature applies to them. When comparing results, confirm which material the source used.

Actin sequestration

The mechanistic core is straightforward. The LKKTETQ motif binds monomeric G-actin, holding a reservoir of unpolymerised actin available for rapid filament assembly. Because cytoskeletal reorganisation underlies cell migration, this places the molecule upstream of essentially every migratory process — endothelial migration in angiogenesis, keratinocyte migration in epithelial closure, and fibroblast recruitment in matrix remodelling.

Reported downstream observations in preclinical models include upregulation of laminin-5, increased endothelial tubule formation, and modulation of inflammatory mediator expression in injury models.

Laboratory characteristics

The synthetic fragment is highly water-soluble and dissolves without difficulty in neutral aqueous diluent. Full-length thymosin beta-4, being a larger and more structured molecule, is more sensitive to interface stress and benefits from a carrier protein in dilute solution.

Both are typically studied in extended-timecourse models rather than acute readouts, since the reported effects are proliferative and migratory rather than immediate signalling events. In tissue-repair work the fragment is frequently paired with BPC-157, the two being studied for complementary angiogenic and cytoskeletal mechanisms.

Frequently asked questions

Is TB-500 the same as thymosin beta-4?: No. Thymosin beta-4 is the full 43-residue protein; TB-500 is a synthetic fragment corresponding to its actin-binding region. They differ in molecular weight and handling, and published literature on one does not automatically apply to the other.
What does actin sequestration mean?: The peptide binds monomeric G-actin and holds a reservoir of unpolymerised actin available for rapid filament assembly, which places it upstream of cell migration processes such as endothelial and keratinocyte movement.
Why are TB-500 and BPC-157 studied together?: They are investigated for complementary mechanisms in tissue-repair models — angiogenic signalling in the case of BPC-157 and cytoskeletal mobilisation in the case of TB-500.